Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

New Cosmetics Operation

11 Jan 2008 07:01

Swallowfield PLC11 January 2008 Swallowfield's new cosmetics operation in Czech Republic Swallowfield plc, the £45m turnover cosmetics, toiletries and household goodssolutions provider that is listed on AIM, has formally opened its new operationin Tabor in the Czech Republic. The production facility, which is designed to provide Swallowfield withsignificant cost efficiencies, will fill, finish and package colour cosmetics,fragrances and other liquid products the company produces for its clients, whichinclude global brands and high street retailers. The 5,000 sq metre facilitywill also undertake gift packaging of toiletry and cosmetic products. Ian Mackinnon, Chief Executive of Swallowfield, said: "In the last 12 months wehave made great strides, with operating profit up 122% to £1.32m for the yearended 30 June 2007. Our new facility in the Czech Republic is part of ourongoing strategy to increase revenues and reduce our cost base. Whilst therewill be an increase in freight costs associated with moving an operationoverseas, the labour costs are approximately a third of those in the UK for thetype of work that will be undertaken in our new operation, thereby providing asignificant net saving. We believe this to be one of the biggest operations of its kind in Europe and asthe facility is operated by us, rather than outsourced to a strategic partner,we feel that this gives us a major competitive edge in the marketplace. We havealready received a lot of interest in our new production facility from majorglobal players in the cosmetics and toiletries industry." The production plant in the Czech Republic forms part of Swallowfield's globalexpansion programme, which also includes the development of a joint ventureoperation in China, which will be unveiled early in the New Year. The openingof the Tabor facility comes on the back of Swallowfield's announcement that ithas unconditionally completed the sale and leaseback of its Lowmoor warehousefacility, which will support the company's expansion programme both in the UKand overseas. The company expects to make a pre-tax profit on this transactionof £1.25m. The factory in Tabor will employ some 100 production staff when fullyoperational and will share the same quality systems that are operated inSwallowfield's two plants at Wellington, Somerset and Bideford, Devon. NOTES TO EDITOR Swallowfield is today a full service provider for brands operating in thecosmetic, personal care and household goods marketplace. This includes marketanalysis; design, formulation and testing of products; packaging design andsourcing; and distribution and stock management. For further press information, please contact: Chris Lawrance, Performance Communications,tel: 0117 9073414; mobile: 0774 7693905 Alan Bulmer, Performance Communications,tel: 0117 9076514; mobile: 07831 654744 Ian Mackinnon, Swallowfield plc,tel: 01823 652219; mobile 07713 501867 Mike Coe, Blue Oar Securities Plc,tel: 0117 933 0020 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Apr 20225:19 pmRNSForm 8.3 - Brand Architekts Group PLC
13th Apr 20224:03 pmRNSForm 8.3 - Offeree - InnovaDerma PLC
13th Apr 20223:22 pmGNWForm 8.3 - Brand Architekts Group plc
13th Apr 20229:26 amRNSForm 8.3 - Brand Architekts Group Plc
13th Apr 20228:48 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
12th Apr 20223:21 pmRNSForm 8.3 - Brand Architekts Group plc - Replace
12th Apr 20222:04 pmRNSForm 8.5 (EPT/RI)
12th Apr 20229:34 amRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:18 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:17 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:14 pmRNSForm 8 (OPD) InnovaDerma PLC
11th Apr 20226:10 pmRNSForm 8 (OPD) - Brand Architekts plc
11th Apr 20224:04 pmRNSForm 8.3 - Brand Architekts Group PLC
11th Apr 20229:06 amRNSForm 8.5 (EPT/RI)
8th Apr 20225:15 pmRNSForm 8.3 - Brand Architekts Group PLC
8th Apr 202210:31 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
7th Apr 20222:40 pmRNSForm 8.4 - Roger McDowell
7th Apr 20222:40 pmRNSDirector/PDMR Shareholding
7th Apr 20229:53 amRNSForm 8.5 (EPT/RI)
6th Apr 20221:10 pmRNSForm 8.4 - Roger McDowell
6th Apr 20221:00 pmRNSDirector/PDMR Shareholding
6th Apr 202211:00 amRNSForm 8.3 - Brand Architekts Group PLC
6th Apr 202210:56 amRNSForm 8.5 (EPT/RI)
5th Apr 202211:45 amRNSForm 8.5 (EPT/RI)
4th Apr 202211:18 amRNSForm 8.5 (EPT/RI)
1st Apr 20221:40 pmRNSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
1st Apr 202211:53 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
31st Mar 20222:54 pmRNSForm 8.3 - Brand Architekts Group Plc
31st Mar 20221:26 pmGNWForm 8.3 - Octopus Investments - Brand Architekts Group plc
31st Mar 20229:52 amBUSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
31st Mar 20227:01 amRNSRecommended Merger with InnovaDerma Plc
31st Mar 20227:00 amRNSHalf-year Report
1st Mar 20227:00 amRNSBoard Appointment
14th Feb 202210:07 amRNSHolding(s) in Company
6th Dec 20214:01 pmRNSHolding(s) in Company
6th Dec 20213:56 pmRNSHolding(s) in Company
29th Nov 20213:54 pmRNSResult of AGM
4th Nov 20213:25 pmRNSAnnual Report and Accounts & Notice of AGM
12th Oct 202112:40 pmRNSGrant of Options
6th Oct 20213:51 pmRNSHolding(s) in Company
5th Oct 202111:23 amRNSHolding(s) in Company
4th Oct 20212:31 pmRNSHolding(s) in Company
30th Sep 202110:23 amRNSLaunch of marketplace: The Unexpekted Store
28th Sep 20212:56 pmRNSDirector/PDMR Dealing
28th Sep 20217:00 amRNSFinal Results
16th Sep 20217:00 amRNSNotice of Investor Presentation
20th Jul 20217:00 amRNSTrading Update
2nd Jul 202110:57 amRNSHolding(s) in Company
29th Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.